18 Jul 2024 --- Kintor Pharmaceutical introduces a topical anti-hair loss solution for androgenetic alopecia (AGA) after recently receiving the International Nomenclature Cosmetic Ingredient (INCI) for its in-house developed KX-826. The cosmetics product contains KX-826 as the main ingredient. “KX-826 gel is a well-targeted topical androgen receptor antagonist,” details the clinical-stage biotechnology company.
